Wednesday, July 8, 2026

pharma · Irritable Bowel Syndrome With Constipation · Chronic Constipation · IRWD

IRONWOOD PHARMACEUTICALS

IRONWOOD PHARMACEUTICALS is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker IRWD. Primary therapeutic focus areas include Irritable Bowel Syndrome With Constipation, Chronic Constipatio

100 Summer Street, Boston, MA 02110, US HQ
1998 Founded
262 Employees
Public company Type
IRWD · NYSE Ticker
Company details
Status
Public
HQ
100 Summer Street, Boston, MA 02110, US
Founded
1998
Employees
262
Programs
33
Drugs
11
Patents
45
Clinical program

Microgestin®

Phase 1 · small molecule · Healthy Volunteers

Microgestin® for Healthy Volunteers is a Phase 1 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

← All IRONWOOD PHARMACEUTICALS INC projects Phase 1 small molecule completed

Internal code C3718-103

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
IRONWOOD PHARMACEUTICALS INC
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Volunteers
Status
completed
Trials
1